initial public offerings (IPOs) trading on American exchanges

Thursday, May 27, 2021

Day One Biopharmaceuticals (DAWN) began trading on the Nasdaq on Thur 27 May 21

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. 
  • Sector(s): Healthcare
  • Industry: Biotechnology
  • Full Time Employees: 20
  • Incorporated in 2018 
  • Headquartered in South San Francisco, California
Opened at $25 after pricing 10 mln share IPO at at $16.00 per share, at the high of the $14-16 expected range

No comments:

Post a Comment